West-Ward Columbus Inc. FDA Inspection Record
West-Ward Columbus Inc. is an FDA-registered facility (FEI 1510690) located in Columbus, OH, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK; PARTICLE SIZE REDUCTION. RegDataLab tracks 28 FDA inspections and 2 compliance actions at this facility.
What FDA found at this site
- Latest inspection
- Sep 18, 2026: No Action Indicated (NAI)
- Inspections on record
- 28 (4 VAI, 24 NAI)
- Last OAI inspection
- None on record
- Warning letters
- 2 listed by FDA for this FEI, latest Mar 30, 2009
- Recalls as the recalling firm
- 41, latest Oct 20, 2026
- Import refusals
- 9
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Sep 18, 2026 | No Action Indicated (NAI) | No citations listed |
| Apr 30, 2026 | No Action Indicated (NAI) | No citations listed |
| Jan 17, 2025 | No Action Indicated (NAI) | No citations listed |
| Jul 23, 2024 | No Action Indicated (NAI) | No citations listed |
| Sep 15, 2022 | No Action Indicated (NAI) | No citations listed |
| Nov 22, 2019 | No Action Indicated (NAI) | No citations listed |
| Apr 16, 2019 | No Action Indicated (NAI) | No citations listed |
| Apr 18, 2018 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Label storage access limited to authorized personnel (21 CFR 211.122(d)) |
| Sep 19, 2017 | No Action Indicated (NAI) | No citations listed |
| Aug 29, 2017 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Oct 20, 2026 | Class II | D-0165-2027 | Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma… and 1 more product CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit. |
| Oct 6, 2026 | Class II | D-0076-2027 | Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for… Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity. |
| Aug 24, 2026 | Class II | D-0831-2026 | Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500… Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU). |
| Apr 7, 2026 | Class II | D-0526-2026 | Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose… This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side. |
| Dec 19, 2024 | Class III | D-0183-2025 | Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed… Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only. |
| Sep 22, 2023 | Class III | D-0066-2024 | Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only… Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet… |
| Jul 22, 2020 | Class III | D-1490-2020 | Leucovorin Calcium Tablets USP, 10 mg, Rx only, 24 Tablets per bottle, Distr. by… Failed Tablet/Capsule Specifications: Tablets are imprinted with the incorrect identification code. |
| May 13, 2020 | Class II | D-1274-2020 | Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC… Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification… |
| May 13, 2020 | Class III | D-1282-2020 | Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward… Failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants. |
| Sep 9, 2019 | Class II | D-1863-2019 | Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by… Failed Impurities/Degradation Specificattion |
FDA record score
22 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
30 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall D-0165-2027, this FEI as the recalling firm | Oct 20, 2026 | 4 x 1 | 4 |
| Class II recall D-0076-2027, this FEI as the recalling firm | Oct 6, 2026 | 4 x 1 | 4 |
| Class II recall D-0831-2026, this FEI as the recalling firm | Aug 24, 2026 | 4 x 1 | 4 |
| Class II recall D-0526-2026, this FEI as the recalling firm | Apr 7, 2026 | 4 x 1 | 4 |
| Inspection classified VAI | Apr 18, 2018 | 6 x 0.25 | 1.5 |
| Class II recall D-1274-2020, this FEI as the recalling firm | May 13, 2020 | 4 x 0.25 | 1 |
| Class II recall D-1863-2019, this FEI as the recalling firm | Sep 9, 2019 | 4 x 0.25 | 1 |
| Class II recall D-1024-2018, this FEI as the recalling firm | Jul 24, 2018 | 4 x 0.25 | 1 |
| Class II recall D-0437-2017, this FEI as the recalling firm | Dec 22, 2016 | 4 x 0.25 | 1 |
| Inspection classified VAI | Oct 21, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0008-2017, this FEI as the recalling firm | Oct 3, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1279-2015, this FEI as the recalling firm | Jul 24, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1085-2015, this FEI as the recalling firm | Apr 2, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jun 26, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1427-2014, this FEI as the recalling firm | May 1, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-002-2014, this FEI as the recalling firm | Apr 3, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-067-2013, this FEI as the recalling firm | Nov 5, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jan 20, 2011 | 10 years or older, so it adds no points | 0 |
| Class II recall D-829-2011, this FEI as the recalling firm | Nov 30, 2010 | 10 years or older, so it adds no points | 0 |
| Class II recall D-164-2011, this FEI as the recalling firm | Oct 28, 2010 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Mar 30, 2009 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Mar 30, 2009 | 10 years or older, so it adds no points | 0 |
| Class I recall D-196-2009, this FEI as the recalling firm | Jul 10, 2008 | 10 years or older, so it adds no points | 0 |
| Class II recall D-196-2008, this FEI as the recalling firm | Mar 3, 2008 | 10 years or older, so it adds no points | 0 |
| Class II recall D-840-2007, this FEI as the recalling firm | May 14, 2007 | 10 years or older, so it adds no points | 0 |
| Class II recall D-335-6, this FEI as the recalling firm | Jul 31, 2006 | 10 years or older, so it adds no points | 0 |
| Class I recall D-337-6, this FEI as the recalling firm | Jul 10, 2006 | 10 years or older, so it adds no points | 0 |
| Class II recall D-266-6, this FEI as the recalling firm | May 24, 2006 | 10 years or older, so it adds no points | 0 |
| Class II recall D-468-5, this FEI as the recalling firm | Jul 26, 2005 | 10 years or older, so it adds no points | 0 |
| Class II recall D-150-5, this FEI as the recalling firm | Jan 17, 2005 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing West-Ward Columbus Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check West-Ward Columbus Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Hikma Pharmaceuticals USA INC.
- Location
- Columbus, OH (US)
- Registration Expires
- Dec 31, 2026
- Operations
- ANALYSIS; LABEL; MANUFACTURE; PACK; PARTICLE SIZE REDUCTION
- Source
- decrs